MedPath

CELESTONE SOLUSPAN

CELESTONE SOLUSPAN

Approved
DIN Number

00028096

Drug Class

Human

Market Date

Dec 31, 1965

Company
HC

organon canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00028096
AIG Number0206301001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
H02AB01 BETAMETHASONE
Product Specifications
Dosage FormSuspension
Route of AdministrationIntra-Articular ,  Intramuscular ,  Intradermal ,  Intrabursal
AHFS Classification68:04.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE)Active
Strength: 3 MG / ML
Monograph: BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE)
BETAMETHASONE ACETATEActive
Strength: 3 MG / ML
Monograph: BETAMETHASONE ACETATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.